ConductScience.org, home

Paper41449347

Comparative analysis of drug susceptibility among different Mycobacterium abscessus morphotypes.

Cheng K and 5 others. BMC Microbiol, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Comparative analysis of drug susceptibility among different Mycobacterium abscessus morphotypes. Papers, record 41449347. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41449347

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative analysis of drug susceptibility among different Mycobacterium abscessus morphotypes.
PubMed
Journal
BMC Microbiol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Comparative Study
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-07-03
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cheng KKai
2Guo JJiaying
3Shang YYuanyuan
4Ren WWeicong
5Zhao WWeijie
6Li SShanshan

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mycobacterium abscessusMajor topic
Anti-Bacterial AgentsMajor topic
Drug Resistance, Multiple, BacterialMajor topic
Microbial Sensitivity Tests
Humans
Clofazimine
Mycobacterium Infections, Nontuberculous
Phenotype
Genotype
Fluoroquinolones

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Z221100007422056Beijing Municipal Science & Technology CommissionPubMed
20230484295Beijing Nova ProgramPubMed

Source PubMed

Download CSV of grants

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140199904A glycosylated lipooctapeptide promotes uptake and growth of Mycobacterium abscessus in the host.Nat Commun2025https://conductscience.org/library/papers/40199904PubMed
220833823Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.Am J Respir Crit Care Med2011https://conductscience.org/library/papers/20833823PubMed
315295701Production of exopolysaccharide by Burkholderia cenocepacia results in altered cell-surface interactions and altered bacterial clearance in mice.J Infect Dis2004https://conductscience.org/library/papers/15295701PubMed
417277290An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.Am J Respir Crit Care Med2007https://conductscience.org/library/papers/17277290PubMed
532617011Antimicrobial Susceptibility of Mycobacterium abscessus Complex Clinical Isolates from a Chinese Tertiary Hospital.Infect Drug Resist2020https://conductscience.org/library/papers/32617011PubMed
633731862Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates.Sci Rep2021https://conductscience.org/library/papers/33731862PubMed
731512604A multilocus sequence typing scheme for Mycobacterium abscessus complex (MAB-multilocus sequence typing) using whole-genome sequencing data.Int J Mycobacteriol2019https://conductscience.org/library/papers/31512604PubMed
823030647Phagocytosis and cytokine response to rough and smooth colony variants of Mycobacterium abscessus by human peripheral blood mononuclear cells.APMIS2013https://conductscience.org/library/papers/23030647PubMed
911158161Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis.J Clin Microbiol2001https://conductscience.org/library/papers/11158161PubMed
1031540480The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin.Antibiotics (Basel)2019https://conductscience.org/library/papers/31540480PubMed
1134108590Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.Sci Rep2021https://conductscience.org/library/papers/34108590PubMed
1226288841Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens.EBioMedicine2015https://conductscience.org/library/papers/26288841PubMed
1327385830Deletion of a dehydratase important for intracellular growth and cording renders rough Mycobacterium abscessus avirulent.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/27385830PubMed
1430687747In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics.Biomed Res Int2018https://conductscience.org/library/papers/30687747PubMed
1537862100Population heterogeneity in Mycobacterium smegmatis and Mycobacterium abscessus.Microbiology (Reading)2023https://conductscience.org/library/papers/37862100PubMed
1624197890Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens.J Clin Microbiol2014https://conductscience.org/library/papers/24197890PubMed
1740105336Subspecies distribution and drug-resistance characteristics of Mycobacterium abscessus complex clinical isolates in South China.Microbiol Spectr2025https://conductscience.org/library/papers/40105336PubMed
1822290346Mycobacterium abscessus: a new antibiotic nightmare.J Antimicrob Chemother2012https://conductscience.org/library/papers/22290346PubMed
1916735722Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype.Microbiology (Reading)2006https://conductscience.org/library/papers/16735722PubMed
2032636299Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.Eur Respir J2020https://conductscience.org/library/papers/32636299PubMed

See all 26 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41449347

GET https://conductscience.org/api/papers/v1/41449347/references?page=2